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ABSTRACT
MECHANISM OF ACTION OF PENTOBARBITAL




Pentobarbital (PB) vasodilates dog mesenteric and cerebral arteries
precontracted with KC1, PGF2a, caffeine or norepinephrine. It is postulated
that PB causes this dilation by reducing Ca2+ influx as a non-specific Ca2-*- 
channel blocker, or decreasing intracellular Ca2+ release. We examined PB
effects on intracellular Ca2+ release (ICR) and extracellular Ca2+ influx (ECI)
by stimulating Sprague-Dawley rat tail artery rings with either 100 mM
KC1, 50 pM phenylephrine (PE), or two different electrical field
stimulation (EES) parameters: tetrodotoxin (TTX; 1 pM) sensitive, or 
perivascular nerve, (NEFS) stimulation (10 Hz, 0.3 ms, 50 V, 30 sec), and
direct smooth muscle (MEFS) stimulation in the presence of TTX (10 Hz, 3
ms, 50 V, 30 sec). Rings, preloaded at 1 g, were immersed in an organ bath
filled with Krebs solution at 37°C, and aerated with 95% 02:5% CO2. PB
(1 mM) attenuated only the tonic component of contraction induced by PE 
and NEFS by 80%, but reduced KC1 and MEFS total contraction by 80%. PE 
and NEFS induces ICR from the sarcoplasmic reticulum and, with diacyl 
glycerol, opens receptor operated Ca2+ channels. KC1 and MEFS increases
ECI. PB is also thought to increase fluidity of both artificial and nerve
membranes. We examined ECI as a function of altered membrane fluidity
in Ajrs (embryonic rat aortic) VSM cells. Fluidity was increased by 
treatment with docosahexaenoic acid (22:6), a polyunsaturated fatty acid
(PUFA), to compare the effects of PB (30 pM, 20 min). PUFA and/or PB
treatment had no effect on transient ECI in resting cells over a range of
temperatures (32, 34.5, 37, 39.5, 41°C). However, both PUFA and/or PB 
treatment of cells depolarized with 55 mM KC1 in HEPES buffered (pH 7.4)
physiologic saline solution decreased ECI by 25% over the same
temperature range. PUFA/PB combination had an additive inhibitory
effect (45% decrease). These data suggest that PB may increase membrane
fluidity, and thus attenuate the tonic component of contraction in VSM,
implying that PB interferes with ECI and not ICR.
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INTRODUCTION
I. The cardiovascular system
The function of the cardiovascular (CV) system is that of transport. 
This system carries nutrients, waste products and controlling substances to
and from tissues. The CV system consists of the blood, the heart acting as a
pump, and a variety of vessel types.
A. The anatomy of arteries and arterioles
The classification of the vascular system is based on structure and 
function. Arteries are responsible for taking the blood away from the heart.
while veins bring blood back to the heart. The distinguishing feature of 
arteries is the large amount of vascular smooth muscle (VSM). These vessels 
have a wide bore, are of short length, and are compliant. The wide bore and
short length assures that a large quantity of blood can be quickly delivered to 
the periphery with minimal energy loss. Compliance has the effect of 
smoothing the pressure pulse and maintaining left coronary flow. Although 
arteries are innervated by sympathetic nerves, the number of varicosities per
smooth muscle cell is reduced in arteries with thicker walls and the
sympathetic effect is marginal (Hirst and Edwards, 1989).
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The arterioles (<100 Jim) have proportionately more smooth muscle
than arteries, and are also innervated by sympathetic nerves. Sympathetic
stimulation causes VSM to contract, thus reducing the arteriolar diameter 
with a resultant increase in resistance. A large pressure drop occurs across the
small arteries and arterioles because of this resistance.
The small arteries and arterioles are composed of three layers:
Tunica intima, the inner most layer consists of(1)
endothelium.(a)
(b) subendothelial layer of connective tissue, and
internal elastic membrane (diFiore, 1981).(c)
Tunica media, which consists of(2)
circular and longitudinal smooth muscle fibers - the(a)
primary component.
(b) fine elastic fibers interspersed (diFiore, 1981).
Tunica adventitia, the outer most layer consists of(3)
connective tissue - small nerves lie here.(a)
(b) blood vessels (diFiore, 1981).
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II. Vascular smooth muscle
A. Anatomy
The focus of this paper is on the function and regulation of vascular
smooth muscle contraction; therefore, we will take a closer look at the tunica
media, and vascular smooth muscle (VSM) in particular. A VSM cell is 
40-60 pm in length, 4 pm in diameter, and spirally oriented at 80° angle from
the path of the vessel. There are about 7,000 VSM cells per cm of vessel
length. Larger vessels contain up to 40 layers of VSM cells, whereas the
smallest arterioles have only one layer. Each VSM cell has a nucleus, several
mitochondria and scant sarcoplasmic reticulum.
Unlike striated muscle, VSM is not organized into myofibrils, and
Z-disks are missing. Dense bodies and dense areas, functional equivalents of
Z-disks, form bands around the membrane, and are attachment points for
thin filaments. Desmin, an intermediate filament, is prominent in VSM and
links dense bodies and dense areas forming a cytoskeletal network. There is
about two times more actin and tropomyosin per cm2 in VSM than striated 
muscle, generally aligned along the long axis of the cell. VSM has, however, 
only one fourth the myosin that striated muscle has. Myosin filaments are 
arranged in groups of three to five and surrounded by many thin filaments.
which, in turn, are connected at each end to the dense bodies and dense areas.
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B. Vascular smooth muscle membrane
1. Properties of VSM membrane
The membrane contains many caveoli or invaginations. VSM
membrane consists of a phospholipid bilayer, each with a hydrophobic and 
hydrophilic moiety. The hydrophobic moieties, the fatty acid chains of both
bilayers, are in contact with each other and are not exposed to either the inner 
or outer environment. The hydrophilic moiety consists of a glycerol 
framework with an attached polar phosphate molecule. There is a
hydrophobic moiety on each membrane surface, one exposed to the inside
and the other to the outside of the cell (Chapman, 1975).
In the anhydrous condition, the melting point of the membrane is
100°C This transition temperature denotes the change of state from a
crystalline gel to a liquid crystal. In a liquid crystal state the interior of the
bilayer is more fluid than the two hydrophilic moieties exposed to the
aqueous milieu. With water present, as occurs physiologically, the transition 
temperature drops to about 42°C. The membrane is in a gel state when the 
temperature is below 42°C and in a more fluid state - liquid crystal state -
when it is above 42°C (Chapman, 1975).
Floating like icebergs in the sea, integral and peripheral proteins 
intersperse in this gelatinous phospholipid bilayer and form part of the 
membrane. Integral proteins can be divided into three components: one
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protruding out of the cell, a middle portion inside the membrane, and one 
extending into the cell. These proteins are tripartite, hydrophobic inside the 
membrane and hydrophilic at both ends. Peripheral proteins are only loosely
attached to the membrane, and consist of only a hydrophilic portion.
Peripheral and integral proteins form channels, pores, gap junctions, or
receptors allowing each cell to communicate with its environment
(Singer, 1975).
A change in electrical charge across the membrane, or an attachment of
a substance to a receptor, can trigger a conformational change of a channel
protein causing it to be in an open state. A lipid annulus surrounds the
channel and assists in maintaining the protein in a functional
conformational state, thus allowing ions to pass through the channel. If the
annular phospholipids are denatured, the change in conformational state of
the protein cannot be maintained, inhibiting the channel from opening, thus
not allowing ions to pass through. The annulus is functional when the
membrane is in the gel but not in the liquid crystal state (Singer, 1975; Lee,
1976).
Gap junctions, specialized protein channels, connect VSM cells 
together allowing quick and efficient communication between the cells. This 
enables the muscle layer to act as a syncytium. Abe and Tomita (1968) 
suggested that smooth muscle exhibits the electrical properties of a cable. This
6
indicates that VSM cells, even though they are arranged in a complex 
manner, will not act independently of one another, but as a unit.
2. Resting membrane potential
The membrane potential (Vm) of VSM in vitro is in the range of -60 to 
-75 mV. The equilibrium potential of the various ions (Ei0n) is: ENa= +50 mV,
Ek= -90 mV, Eci= -20 mV, Eca^ +150 mV (Hirst and Edwards, 1989). Resting
Vm is primarily determined by the transmembrane K+ gradient and K+
conductance (gK)- The membrane exhibits preferential permeability and there
is an independent concentration gradient for each ion. In the cytoplasm, 
there is a high concentration of K+ (130-160 mM) and a low concentration of
Na+ (10-20 mM), Cl- (40-70 mM), and Ca2+ (1 |iM to 10 nM). In the
extracellular space, the opposite is true (K+, 3-5 mM; Na+, 150 mM; C1-,
140 mM; Ca2+, 2 mM; Hirst and Edwards, 1989).
A change in membrane permeability will allow ions to flow down 
their respective electrochemical gradients, thus changing Vm. An outward 
current, outward diffusion of K+ for example, hyperpolarizes the membrane, 
while an inward current, such as Ca2+ influx, depolarizes the membrane
(Hirst and Edwards, 1989).
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3. Transport of ions across VSM membrane 
Seven distinct voltage dependent channels (VDC) have been identified
and are characterized as follows:
the inward rectifier K+ channel, activated by(a)
hyperpolarization, allows K+ influx (Hirst and Edwards,
1989);
the delayed rectifier K+ channel allows K+ efflux and is 
activated after a delay by membrane depolarization (Hirst
(b)
and Edwards, 1989);
K(Ca)fast channel allows K+ efflux and is quickly activated(c)
when the intracellular Ca2+ concentration is increased
(Hirst and Edwards, 1989);
K(Ca)siow channel also allows K+ efflux and is slowly(d)
activated when the intracellular Ca2+ concentration (Ca2+i)
is increased (Hirst and Edwards, 1989);
Katp channel allows K+ efflux with a decrease in(e)
intracellular ATP and hyperpolarizes the membrane
making opening of voltage dependent Ca2+ channels less
likely (Nelson el ah, 1990).
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(f) the Casiow channel allows Ca2+ influx, is activated by small
depolarizations and is inactivated slowly with time (Hirst
and Edwards, 1989);
(g) Cafast channel allows Ca2+ influx, is activated quickly by a 
large membrane depolarization and is inactivated quickly
(Hirst and Edwards, 1989);
Other Ca2+ channels are activated by substances that bind to receptors 
and are not as well understood. These receptor operated channels (ROC) also
allow Ca2+ influx (Campbell et ah, 1985; Somlyo and Himpens, 1989; van
Breemen, 1989; Nelson et ah, 1990). ROC differ from VDC in that Ca2+ influx
through ROC can occur at the normal resting membrane potential. When
VDC are activated, stimulation of ROC can result in an additive effect of Ca2+
uptake. This offers evidence that ROC and VDC are independently operated.
Once Ca2+ influx has occurred, two sarcolemmal mechanisms are
responsible for clearing Ca2+ from the cytoplasm (McDonald et ah, 1994). The
Ca2+/Mg2+-ATPase actively extrudes Ca2+ out of the cytoplasm and into the 
sarcoplasmic reticulum (SR). The sarcolemmal Na+/Ca2+-exchanger moves 
three Na+ out for one Ca2+ in at no energy cost. VSM contraction induced by 
depolarization does not occur unless the SR is filled. Bolton (1979) showed
that in order for contraction to occur, intracellular free calcium must rise
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above 0.1 jiM, by either entry of extracellular calcium or release from
intracellular stores.
III. Mechanism of smooth muscle contraction.
VSM regulates arterial and arteriolar diameter in the following
manner:
A. Depolarization
VSM depolarizes in vitro when extracellular K+ ([K+]0) is increased. As 
[K+]0 increases, Vm decreases. When the logarithm of the [K+]0 is plotted 
against Vm/ a non linear relationship is observed. Linearity is expected if the 
sarcolemma is permeable exclusively to K+. That, however, is not the case.
As Vm increases, voltage-dependent Ca2+ channels (VDCC) open making the 
membrane more permeable to Ca2+. Since a large electrochemical gradient
exists for Ca2+, a rapid rise in [Ca2+]i results due to Ca2+ influx (Hirst and
Edwards, 1989).
In vitro the Vm is 20 mV more negative than in vivo, a difference due 
to tonic sympathetic nerve activity. In vivo Vm is very close to the potential 
at which VDCC are opened. Only a small change in Vm is needed to induce
Ca2+ influx (Hirst and Edwards, 1989).
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B. Adrenergic neurogenic stimulation
VSM is innervated by sympathetic nerves which release the
neurotransmitter (NT) norepinephrine (NE), and the cotransmitters (CT)
adenosine triphosphate (ATP) and neuropeptide Y (NPY). These are released
at different times and are eliminated and inactivated at different rates during
stimulation. The role of NPY in modulating VSM contraction is not well
understood. NPY may potentiate vasoconstrictor responses of NE and ATP by
increasing Ca2+ influx through a process that is not well understood
(Edvinsson et al., 1987, Andriantsitohaina et al., 1993).
ATP and NE are released together from the nerves. ATP is removed 
from the receptor area within 50-100 ms which is more than thirty times 
faster than NE clearance. ATP binds to P2X-purinoceptors while NE exerts its
effects via oci- and (X2-adrenoceptors. The concentration of ATP in the cleft is
initially very high and rapidly falls due to the swift clearance. NE release
remains constant throughout stimulation (Bao et al., 1993). The net effect is
Ca2+ influx by various mechanisms. Stimulation of the P2X-purinoceptor
activates VDCC, whereas a-adrenoceptor stimulation causes the initial
release of Ca2+ from the SR. These two factors induce a rapid phasic
contraction. The tonic component of a neuronally-induced contraction is the




Campbell et al. (1985) described the role that phosphoinositide
hydrolysis plays in agonist-induced Ca2+ flux and contraction in rabbit aorta.
They concluded that upon receptor activation, inositol 1,4,5-triphospate (IP3) 
is formed from phospholipase C (PLC) activated phosphoinositol
4,5-diphosphate (PIP2) breakdown. The other metabolite of PIP2 is diacyl
glycerol (DAG) which has been reported to play a role as an activator of Ca2+ 
release and protein kinase C (PKC). The actions of DAG and IP3 may act in a 
synergistic way in bringing about receptor-induced vasoconstriction. 
Phosphatidic acid (PA), formed via phosphorylation of DAG by DAG-kinase, 
has also been shown to cause receptor-induced Ca2+ influx in smooth muscle.
D. VSM contraction
The smooth muscle cell differs from the cardiac and skeletal muscle
cells in that Ca2+ binds to calmodulin instead of troponin. One molecule of 
calmodulin binds four molecules of Ca2+. This calcium-calmodulin complex
combines with myosin light chain kinase (MLCK) and causes 
phosphorylation of the actin-myosin crossbridge, an obligatory step in smooth 
muscle contraction. Crossbridge formation is dependent on (1) the 
concentration of MLCK and myosin phosphatase (MP), enzymes which 
phosphorylate and dephosphorylate the crossbridge respectively, and (2) Ca2+
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concentration. If there is a greater activation of MLCK, contraction occurs. If 
MP is more activated, relaxation results (Murphy, 1989).
What makes the smooth muscle cell so unique from other muscle cells
is that it can go into a latch-state. This occurs when actin and myosin stay
bound for an extended period of time even though myosin may be
dephosphorylated. Because there is no energy utilization during this state.
latch maintains prolonged contraction at little metabolic cost (Rembold, 1991).
IV. Endothelial modulation of vascular tone
The endothelium is capable of producing relaxing and contracting
substances that have an effect on VSM contractile statex thus playing an
important role in the regional modulation of vascular tone. Furchgott and
Zawadzki (1980) first discovered that the endothelium had a crucial role in
acetylcholine- (ACh) induced relaxation of isolated arteries. This occurred
through an agent produced by the endothelium acting on the vascular
smooth muscle, and was named the endothelium derived relaxing factor 
(EDRF). Vasodilator activity resulted from an increase in cGMP in the 
smooth muscle cell produced by direct stimulation of soluble guanylate 
cyclase. Nitric oxide (NO) is believed to be the EDRF, although still a matter of 
discussion (Ignarro et al., 1987; Ghigo et aL, 1993). Several substances, 
including ACh, adenosine diphosphate (ADP), epinephrine, serotonin, and
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bradykinin, stimulate the production of EDRF. Stimulation of endothelial
c^-adrenergic, P2y-purinergic, serotonin (5-HTi), and bradykinin (BK2)
receptors putatively induce EDRF release (Liischer and Vanhoutte, 1990).
Two other substances produced by the endothelium that inhibit
contraction are endothelium derived hyperpolarizing factor (EDHF) and
prostaglandin I2 (PGI2). Stimulation of the muscarinici receptor (Mi)
stimulates the production of an EDHF which makes it more difficult for an 
action potential to occur (Liischer and Vanhoutte, 1990). Histamine,
angiotensin II, acetylcholine, platelet-derived growth factor, hypoxia.
increased[Ca2+]i, and mechanical perturbation of the endothelium all may 
activate phospholipase A2. In turn, phospholipase A2 liberates arachidonic 
acid from which PGI2 is formed. PGI2 increases cAMP production in VSM
which leads to relaxation (Liischer and Vanhoutte, 1990).
Several contracting factors originate from the endothelium, such as
thromboxane A2 (TXA2), prostaglandin F2a (PGF2«)/ endothelin-1, endothelin-
2, and endothelin-3. These substances cause VSM contraction by activating 
phospholipase C and, ultimately, releasing Ca2+ from intracellular stores
(Liischer and Vanhoutte, 1990).
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Pentobarbital and its effects on vascular smooth muscleV.
A. History of anesthetics
Prior to anesthetics, the most indispensable people involved in
surgeries were the strong men who held down struggling patients while the 
surgeon worked feverishly to finish the procedure. Two early anesthetics.
nitrous oxide and ether, ushered in the much welcomed era of anesthetics. In
1864, Adolph von Baeyer introduced barbituric acid, which results from the
condensation of malonic acid and urea. Derivatives of barbituric acid, of
which pentobarbital (PB) is one example, are called barbiturates. Barbiturates
have long been used as the agent of choice to induce anesthesia and 
euthanasia in laboratory animals. PB is derived by substituting ethyl at the
Rsa and 1-methylbutyl at the Rsb positions in place of hydrogen molecules.
B. Effects of PB on the cardiovascular system
The first reports on the effects of PB were those observed on the
systemic circulation and cardiac function. In 1943, Corcoran and Page were 
the first to report a rise in mean arterial pressure in dogs following PB 
anesthesia (30 mg/kg ip.). Brodie et al. (1953), investigated the fate of
pentobarbital in man and dog. They observed that PB was extensively 
localized in body fat, thus allowing PB to act as a long lasting anesthetic.
Olmsted and Page (1966) examined PB-induced hemodynamic changes in
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dogs during anesthesia. They reported an increase in mean arterial pressure 
and in heart rate. Reductions in stroke volume and pulse-pressure were also
observed.
C. PB effects on VSM
Altura and Altura (1974) investigated the effects of anesthetics, PB in
particular, on arterial and venous smooth muscle. They reported that
PB, in anesthetic concentrations (0.01 to 1 mM), inhibited(1)
spontaneous spike activity in rat aortic strips (RAS) and portal
veins (PV);
PB attenuated contractions induced by epinephrine (EPI) and KC1(2)
in a dose-dependent manner;
PB caused a non-competitive type displacement of the dose-(3)
response curves for EPI and KC1;
PB attenuated Ca2+-induced contractions of K+-depolarized RAS(4)
and PV, along with a dose-dependent displacement of these
dose-response curves to the right; and
(5) PB rapidly relaxed drug-induced contractions of RAS and PV. 
They further observed that venous muscle is much more sensitive to the 
inhibitory actions of PB than arterial muscle. These investigators concluded 
that PB can exert profound depressant effects on VSM, probably by acting on
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the movement and/or translocation of Ca2+, and not by direct action on the
receptor. However they did not discuss reasons for the potential significance 
of PB's ability to inhibit spontaneous spike activity. PB may stabilize the 
membrane in some way, making it less responsive.
Altura and Altura {1975a, 1975b) also explored the role of various 
barbiturates on aortic and venous smooth muscle contractility. The order of
effectiveness among the various barbiturates was thiopental
(TI) > secobarbital = PB > amobarbital > phenobarbital > barbital. They
concluded that barbiturates may:
act directly to decrease availability of Ca2+ to the contractile 
machinery either at and/or beyond the cell membrane.
(1)
block Ca2+ influx across the membrane as Ca2+ channel blockers(2)
do, and
act intracellularly.(3)
The findings that support their first conclusion is that K+ and CaCl2 induced
contractions are: (1) dose-dependently inhibited by all of the barbiturates and 
(2) both dependent on extracellular Ca2+ to pass through a membrane that is
highly permeable in the presence of high [K>]. Evidence to support their 
second conclusion was that since PB affects Ca2+ uptake and distribution in 
mammalian cardiac muscle (Nayler and Szeto, 1972), PB may act similarly in 
VSM. The findings that support their last conclusion include: (1) barbiturates
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penetrate both the cell membrane and the cell rapidly, (2) barbiturates
attenuate catecholamine-induced contractions, and (3) there is a downward
shift of the log-dose-response curve for agonists in the presence of
barbiturates concomitant with a decrease in maximal developed tension
(Seeman, 1972). Therefore, with receptor-mediated contraction, not only is
the IP3 second messenger system affected and Ca2+i release from the SR
inhibited, but the sustained contraction due to Ca2+ influx is also attenuated.
Altura et al. (1980) studied the effects of PB on Ca2+ uptake in VSM
looking for direct evidence regarding PB's antagonistic or inhibitory effects on




total exchangeable Ca2+, which is membrane bound and(3)
intracellular Ca2+.
They concluded that PB-induced relaxation may be due to a significant 
inhibitory effect on Ca2+ exchangeability and Ca2+ movement in SM. The
question that these observations raised is the possibility of PB acting as a Ca2+
channel blocker.
Wendling and Harakal (1985) attempted to answer this question by 
comparing the actions of PB and verapamil, a voltage dependent Ca2+
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channel blocker, on KC1 and PGF2a stimulated canine cerebral and peripheral
arteries. KCl-induced vasoconstriction is maintained by influx of
extracellular Ca2+ through voltage-dependent Ca2+ channels activated by 
membrane depolarization (Cauvin et ah, 1983), while PGF2a-induced
vasoconstriction is maintained primarily by the influx of extracellular Ca2+ 
through receptor-operated Ca2+ channels (ROCC) and secondarily by the
release of Ca2+ from intracellular stores (Flester et al,, 1980). Wendling and
Harakal further showed that PGF2a could induce a small but still significant
vasoconstriction in a Ca2+-free media while KC1 could not. They concluded 
that PB acted as a non-specific antagonist of Ca2+ influx blocking ROCC and 
VDCC indiscriminantly, rather than a specific and more potent Ca2+ channel
blocker, such as verapamil. These findings suggest that PB is inhibiting Ca2+
influx through VDCC and ROCC without blocking the channel directly.
Questions that remain unanswered are: how is PB inducing this inhibition;
how is it inhibiting the effects of VDCC and ROCC stimulation; and is PB 
affecting the membrane, thus indirectly affecting VDCC and ROCC?
Taga et al. (1990 ) compared the effects of TI, PB, and ketamine (ket) on 
endothelin (E) generated constriction of porcine cerebral arteries. E, which 
produces vasoconstriction through activation of Ca2+ influx (Saito et al., 1989), 
induced slightly higher maximal contractions than KCl-induced maximal
contractions. In Ca2+-free media, E and KC1 did not induce contractions.
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E contractions, caused after restoration of Ca2+, were 125±11.6% that of KC1.
XI and PB (>0.3 mM) and ket (1 mM) attenuated while diltiazem (1 jiM)
abolished E-induced contractions. Taga et al. concluded that:
E-induced contractions were highly susceptible to diltiazem.(1)
E caused marked contractions in preparations incubated in Ca2+- 
free media and followed by reintroduction of Ca2+, and
(2)
diltiazem attenuated E-induced contractions to a greater degree(3)
than PB or ket.
This study further supports the idea that PB does not mimic the actions of a
Ca2+ channel blocker, since it does not act on the channels directly.
In 1990, Butler et al. investigated the effects of various euthanasia
techniques on vascular smooth muscle contractility. They compared
decapitation to PB overdose, carbon dioxide overexposure, and combinations
of decapitation with carbon dioxide, ether, and methoxyflurane. They found
no differences in VSM contractility in any of these treatments. They observed 
that any changes that may be induced by PB anesthesia are reversed by the end
of an equilibration period.
In 1990, Moriyama et al compared the effects of two thiobarbiturates 
thiamylal (TA) and TI and one oxybarbiturate (PB) on dog cerebral and 
mesenteric arteries precontracted with KC1 and PGF2a- They reported that
Ca2+-induced contractions were attenuated by TA (1 mM) and PB (1 mM), and
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were endothelium-independent. This attenuation was greater in arteries
treated with KC1 than PGF2a- Ca2+ antagonists blocked KC1 stimulated
depolarization-dependent Ca2+ influx more than PGF2a stimulated receptor-
mediated Ca2+ influx. This led to the conclusion that barbiturate-induced
vasorelaxation was associated in part with a Ca2+ channel blocking action.
Since the barbiturates also inhibited PGF2a-induced contractions, an
intracellular mechanism of action was also suspected. They suggested that
the intracellular action of barbiturate-induced vasorelaxation may be due to:
inhibition of release of Ca2+ from intracellular stores.a)
enhancement of sequestration of Ca2+i,(2)
a direct effect on contractile proteins, or(3)
(4) a direct effect on calmodulin.
The last two are not appropriate explanations since the muscle contracts so
long as Ca2+ is able to be delivered into the cell.
Lee (1976) looked at the effect of PB on the transition temperature of a
single layer artificial membrane. He reported that PB lowered the transition 
temperature of this membrane causing the membrane to be in a crystal-liquid 
state at body temperature. When the membrane is in this state, the Na+ 
channels that are embedded in this membrane cannot remain open once 
activated. Garcia-Martinez et ah (1989) suggested that hydrophobic drugs, like 
PB, can inhibit the (Ca2+/Mg2+)-ATPase by disrupting the lipid annulus
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around the protein in nerve cells. From their results, they concluded that PB 
changes the ATPase conformation, rendering it inactive. Investigating the 
effect of PB on the sarcoplasmic reticulum (Ca2+ + Mg2+)-ATPase, Fernandez-
Salguero et al (1990) found that PB changed the conformational state of the
annulus around the (Ca2+ + Mg2+)-ATPase, inactivating it. These
observations suggest that PB may in fact inhibit Ca2+ uptake by the SR in
VSM. This contradicts the possibility that PB attenuation of VSM contraction
is by enhancing the sequestration of Ca2+i.
In 1991, Nakamura et al. investigated the intracellular action of TA on
dog mesenteric arteries. Treatment with atropine, propranolol, 
diphenhydramine, cimetidine, indomethacin, aminophylline, or methylene 
blue did not alter the vasodilatory effect of TA. This suggests that cholinergic,
histaminergic Hi and H2, and prostaglandin-related mechanisms.
p-adrenergic receptor, and adenosine-related mechanisms, as well as the
activation of soluble guanylate cyclase are unlikely to be the mechanisms 
involved in attenuating VSM contraction. This strengthens the hypothesis 
that PB attenuation of VSM contraction is not by means of receptor
inhibition.
Yakushiji et al. (1992) compared the vasorelaxant effects of TI with that 
of PB. VSM was prepared with saponin and skinned. Saponin rendered the 
plasma membrane porous, thus the influence of Ca2+ movement across the
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membrane could be differentiated. Vasoconstriction was induced by three
different mechanisms: KC1, caffeine (caf), and NE. In saponin treated.
skinned VSM preparations, lower concentrations of TI (>10 pM) inhibited
caf-induced contractions while PB concentrations (0.3 mM) had no effect.
They concluded that the vasodilatory effects of PB were due to inhibition of
Ca2+ influx through both voltage-dependent and receptor-operated channels.
The vasodilatory effects of TI, on the other hand, were not limited to the 
plasma membrane. This is the first report to limit PB effects to the
sarcolemma and exclude PB intracellular actions.
In summary, PB induces vascular smooth muscle relaxation of vessels 
precontracted with various agonists. These effects are reversible. The
mechanism of vasodilation is not known. There seems to be a consensus that
PB acts in part by inhibiting Ca2+ influx. Questions still remain regarding PB's
actions within the intracellular environment and the mechanism by which
Ca2+ influx is inhibited. Does PB attenuate pharmacologically and electrically
stimulated contraction of VSM in a non competitive manner? Is the PB 
attenuation of VSM contraction mediated by the endothelium? Does PB
affect the propagation of depolarization in VSM? Does PB inhibit Ca2+
uptake, thus attenuating VSM contraction, rather than affecting intracellular
Ca2+ release? Does PB increase membrane fluidity, thus preventing the
opening of Ca2+ channels and ultimately inhibiting Ca2+ uptake?
MATERIAL AND METHODS
I. General methods (rat)
Male adult Sprague-Dawley rats (200-300 g) were decapitated. The
ventral tail arteries were removed and placed in Krebs physiological solution
containing NaCl 118, KC1 5.4, CaCl2 2.5, NaHCOs 12.5, MgS04 1.12, KH2PO4
1.2 and glucose 11 (mM) at pH 7.4. Artery rings were cut into 3 mm segments
and were mounted in a 5 mL organ bath (Fig. 1). The organ bath and Krebs
solution were bubbled continuously with 95% 02 and 5% C02 and
maintained at 37°C. The rings were equilibrated for 1 hr under these
conditions. The solutions in the baths were changed every 15 minutes.
Contractile tension was measured using a Grass force transducer (FT03C)
connected to a MacLab/4 analog to digital interface and recorded on a
Macintosh Ilsi using Chart software (version 3.3.6). Muscular electrical field
stimulation (MEFS) and neuronal electrical field stimulation (NEFS) were
achieved by stimulating the vessel segments via two electrodes which were
placed on either side. The stimulator was a Tektronix pulse generator - 
waveform generator combination which delivered a rectangular pulse. As 
the Krebs solution in the baths is a weak electrolyte, the stimulator that was





















































amplify the output of the stimulator to ensure that each bath received the
appropriate current (Fig. 2).
A. Length-tension relationship
As in skeletal and cardiac muscle, vascular smooth muscle (VSM) has
an optimal preload, or initial length, at which maximal tension can be 
developed (Price et al., 1981). To determine this optimal load, the vessel 
segments were stretched by various preloads (0-1.5 g) and stimulated with
100 mM KC1. The optimal preload, determined to be 1 g, was used in all
preparations. After the 1 hr equilibration period was over, the vessels were
set at the 1 g preload by stretching them at a rate of 250 mg per 15 min.
B. Dose Response Relationships
A dose-response relationship for VSM contraction was determined 
using various agents in order to find their maximum. VSM was activated
pharmacologically, with potassium chloride (KC1; 1 mM to 1 M) and
phenylephrine (PE; 0.1 pM to 1 mM), and electrically, with muscular (M) and
neuronal (N) electrical field stimulation (EPS). Increasing doses of the agonist
were given in logarithmic steps and the maximal contraction of the vessel 
segment was measured in grams of developed tension (g). Pulse duration
































Tektronix Type 162 r Q50 V
I
I




Tektronix Type 161 out to bathI
2.2 KQ.| Buffer Amplifier
Pulse Generator
29
held constant while frequency was increased in logarithmic increments from
0.16 to 100 Hz. The bath was rinsed twice with Krebs solution and 15 min
were allowed for tissue equilibration before proceeding to the next stimulus.
Tetrodotoxin (TTX; 10 pM) was used to block nerve stimulation and
neurotransmitter release during MEFS. Once we found the concentration or
stimulus at which the maximal contractile response was elicited, in 
experiments henceforth, we used the concentration or stimulus which 
stimulated 70% of the maximal response (70%max). We chose the 70% of
maximal level since it elicited consistent responses.
C. Dose-response relationships with pentobarbital
The above described dose-response experiments were repeated in the
presence of pentobarbital (PB). This was done to understand how PB
attenuates VSM contraction, to see if the inhibition occurs in a competitive
manner, and to establish the inhibitory concentration at which 70% of the
maximal response is blocked by PB (IC70). The vessel segments were
incubated with the various doses of PB (1 nM to 10 mM) for 20 min prior to
stimulation.
Since PB solutions at high concentrations (>10 mM PB) are highly basic 
(8.5 pH), experiments were conducted to study the effect of high pH (8.5) on 
the contractions by adding NaOH to the Krebs solution. It was subsequently
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observed that the pH of the Krebs solution containing PB was measured to be
7.4 after a 20 min exposure to 5% CO2. Therefore, in order to ensure that the
pH was 7.4 and to rule out any other possible pH effects, CO2 was bubbled into 
the krebs solution containing PB for 20 min prior to subjecting the vessel
segments to the solution.
D. Role of endothelium in PB attenuation of VSM
The endothelium from the arterial rings was mechanically or
pharmacologically removed in order to rule out any possible mediation of PB
attenuation of contraction. The mechanical removal of the endothelium was
accomplished by threading a silk suture (6-0) through the vessel segment and
rolling the segment on tissue paper premoistened with Krebs solution. Some
vessel segments were incubated for 20 min with N(l)-nitro-L-arginine
methylester (30 pM L-NAME). L-NAME, a structural analog of L-arginine,
acts as a competitive inhibitor of nitric oxide formation and endothelium
dependent relaxation (Ignarro, 1991). Other segments were incubated with 
methylene blue (10 pM MB) for 10 min. MB is known to inhibit soluble 
guanylate cyclase (King and Brenner, 1991). To ensure inhibition of 
endothelial function, each segment was precontracted with 100 mM KC1 and 
30 pM acetylcholine (ACh) was added to the bath. ACh is known to stimulate 
the production of endothelium derived relaxing factor (Furchgott, 1980). If
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the endothelium were still viable, ACh would induce a vasorelaxation. Once
the endothelium was ruled nonfunctional, contractions stimulated with
70%max of KC1, PE, MEFS, or NEFS in the presence or absence of 1 mM PB
were compared to control.
E. Calcium Studies
1. Role of intracellular Ca2+ on PB-attenuation of VSM
contraction
To examine the role of intracellular Ca2+ ([Ca2+]i) on PB-induced
attenuation of VSM contraction, ethylene glycol-0,0,-bis(2-amoniethyl)-
N,N,N',N' tetraacetic acid (EGTA; 0.1 mM) and Ca2+-free Krebs solution were
used to eliminate extracellular Ca2+ and focus on the effects of PB on [Ca2+]i.
The rings were stimulated with the 70%max for either KC1, PE, MEFS, or 
NEFS, both in the presence and absence of PB (1 mM, 20 min).
2. Role of extracellular Ca2+ on PB-attenuation of VSM
contraction
The role of extracellular Ca2+ ([Ca2+]0) on PB-attenuation of VSM
contraction was examined by using thapsigargin (TSG) to inactivate the 
(Ca2+-Mg2+)-ATPase (Low et al, 1991; Kwan et ah, 1994). The arterial rings
were incubated with TSG (10 pM) for 30 min, and Ca2+i was depleted with
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caffeine (caf; 30 jiM) in Ca2+-free Krebs containing 2 mM EGTA. To ensure
Ca2+i depletion, the vessels were stimulated with either 5 pM PE or 10 Hz
NEFS in normal Krebs solution. The absence of contraction was the indicator
for Ca2+i depletion. Following this verification and PB incubation (1 mM, 
20 min), Ca2+ (3 mM) was reintroduced just prior to stimulation with either
PE or NEFS, in Ca2+ free Krebs.
II. General Methods (frog)
Since VSM acts as a syncytium and exhibits properties of a cable (Abe 
and Tomita, 1968), it might be possible for PB to affect the interaction between 
VSM cells. Does PB affect the propagation of depolarization in VSM? Male 
adult frogs, Rana pipiens(100-150 g), were anesthetized with pentobarbital 
(70 mg/ml). The sciatic nerves were dissected from the spinal cord to the 
knee and the ends were tied and placed into Ringers solution at pH 7.4
containing NaCl, 11.13; KC1, 0.201; CaCl2, 0.102; NaHCOs, 0.238; MgC^,
0.49 (M). The nerves were placed in a nerve chamber and were kept moist
with Ringers solution and aerated with 95% O2 and 5% CO2 at 25°C. The
distance between the stimulating and the recording electrodes was 30 mm. 
With each nerve acting as its own control, the nerves were stimulated with a 
single 1 ms, 4 V pulse. After the initial recordings of latency, amplitude, and
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duration of action potential (AP), the nerves were incubated in 1 mM PB for 
20, 40, and 60 min and the measurements were repeated.
III. General Methods (cells)
Experiments using cell cultures were conducted to determine the effect 
of PB on membrane fluidity and the effect of fluidity on Ca2+ influx. The 
A7rs embryonic aortic smooth muscle cell line was obtained from the 
American Type Tissue Culture Collection. Cells were plated at a density of
5x104 cells/cm2 in Dulbecco modified Eagles medium (DMEM) containing
7.5% fetal calf serum, and kept at 37°C in a humidified atmosphere under 5% 
CO2 and air. At confluency (after 4-5 days) each well contained a monolayer 
of 5x105 cells/cm2. The cells were then placed in test tubes at a density of
2x104 cells/cm2. Cells used in all experiments were from passages 3-5 only.
A. Ca2+ influx studies
The experiments were carried out on confluent cells equilibrated in
HEPES buffered physiologic saline solution (HBPSS; NaCl 145 mM, KC1 
5 mM, MgCl2 1 mM, CaCl2 0.1 mM, glucose 10 mM, HEPES 5 mM, pH 7.4) for
60 min. Influx was determined either by incubating the cells (45 min) in
HBPSS or depolarizing buffer (DB; NaCl 95 mM, KC1 55 mM, MgCl2 1 mM, 
CaCh 0.1 mM, glucose 10 mM, HEPES 5 mM, pH 7.4) containing i^CaCh
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(4 |iCi/ml; Riiegg et al, 1985; Gleason et ah, 1991). The cells were washed
8 times (5 sec/wash) with 1 ml of ice-cold (0-2°C) HBPSS and were solubilized
with 1 ml of 0.1% sodium dodecyl sulfate (SDS; Riiegg et al, 1985; Gleason et 
al, 1991)). Aliquots of the lysate (100 |iL) were analyzed for radioactivity by 
scintillation counting (cpm; Riiegg et al, 1985; Gleason et al, 1991)). Protein
concentration was determined with the bicinchoninic acid (BCA) technique 
(Smith et al, 1985). Calcium uptake was determined from counts derived 
from the lysate of the 45Ca2+ fraction (cpm) divided by the specific activity of 
the 45Ca2+- uptake media (cpm/pmol Ca2+) and expressed as calcium content
(nmol/mg protein; Gleason et al, 1991).
B. Membrane fluidity
1. Polyunsaturated fatty acid treated cells
Incorporation of polyunsaturated acid (PUPA) into cell membranes
increases the membrane fluidity (Robert et al, 1978; Gavino et al, 1981;
Karnovsky et al, 1982; Spector and Yorek, 1985; Aloia et al, 1988). Therefore,
various concentrations of docosahexaenoic acid (22:6), a PUPA, were
introduced into the medium to determine the concentration which would
yield less than 20% cell death. This concentration was 20 |iM, which was used
in all subsequent experiments. To verify that PUPA had been incorporated
into the membrane, cell survivability was tested by placing the cells in
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different temperatures (42 to 47°C) for various durations (15 to 120 min). As
cells incorporate PUFA, they become more sensitive to high temperatures
and more likely to die than control cells.
2. Temperature Study
An alternative method for modifying membrane fluidity is to change
the temperature. As temperature is increased, the membrane fluidity will
increase. Therefore, 45Ca2+ influx was measure for 45 min in control and
PUFA enriched cells at different temperatures (32, 34.5, 37, 39.5, 41°C) under
resting and depolarized conditions in the presence and absence of PB (30 JiM).
IV. Drugs Used and Sources
PE, HEPES, EGTA, TTX, DMEM and PB were obtained from Fisher
Scientific Co, Pittsburg, Pa. BCA protein assay reagent kit was obtained from
Pierce, Rockford, II.
V. Statistical Tests
Data are expressed as mean ± SEM. Student t test, paired t test, and




Preload stretches the vessel segment to an initial length; therefore, 
preload for these conditions is synonymous with length. As the pre-load was 
increased on the vessel segment, the developed tension to a contractile 
stimulus of 100 mM KC1 increased (n=6). Once preload was set above 1 g, the
I.
response did not increase significantly, and was determined to be the
optimum preload (Fig. 3A).
Dose response relationshipsII.
As concentration or strength of stimulus was increased, the developed 
tension increased in a dose dependent manner. The maximum developed
tensions were 3.02 g with 1 M KC1 (n=18; Fig. 3C), 3.81 g with
100 pM phenylephrine (PE; n=18; Fig. 3D), 3.95 g with 50 Hz muscle electrical 
field stimulation (MEFS; n=15; Fig. 3B), and 3.74 g with 50 Hz neuronal
electrical field stimulation (NEFS; n=15; Fig. 3B). The concentrations at
which 70% of the maximal developed tension was achieved (70%max) were
found by interpolation to be 100 mM for KC1, 5 gM for PE, and 10 Hz for both
MEFS and NEFS. Tetrodotoxin (TTX) abolished responses induced by NEFS
at all frequencies.
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(A) Length-tension curve with 100 mM KC1. The abscissa is grams of load which is 
analogous to a change in length, and the ordinate is the tension (g) developed or a 
function of the change in preload (n=6). The brackets indicate ±SEM in this illustration 
and all subsequent illustrations. As the arterial segments are stretched beyond 1 g, the 
developed tension does not rise significantly. The x-axis is an indirect measure of 
length. (B) Stimulus-response relationship with muscle electrical field stimulation 
(MEFS; back line) and neuronal electrical field stimulation (NEFS; red line). MEFS 
was conducted with 50 V, 3 ms duration pulses, in the presence of 10 (iM tetrodotoxin, 
while NEFS was conducted with 50 V,0.3 ms pulses. As the stimulus strength was 
increased (abscissa), the developed tension also increased (ordinate; n=15). The 
maximum developed tension was 3.95 g for MEFS and 3.74 g for NEFS both with 50 Hz 
stimulation. The effective stimulus at which 70% of the maximum developed tension 
is achieved was determined to be 10 Hz for both MEFS and NEFS. (C) Dose-response 
relationship with potassium chloride (KC1). As the KC1 concentration was increased 
(abscissa), the developed tension also increased (ordinate; n=18). The maximum 
developed tension was 3.02 g with 1 M KC1. The effective dose at which 70% of the 
maximum developed tension is achieved was determined to be 100 mM KC1. (D) 
Dose-response relationship with phenylephrine (PE). As the PE concentration was 
increased (abscissa), the developed tension also increased (ordinate; n=18). The 
maximum developed tension was 3.81 g with 100 pM PE. The effective dose at which 
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Dose response relationships with pentobarbital
Increasing doses of pentobarbital (PB) caused a downward shift of the
m.
dose-response curve of all stimuli (Fig. 4). Ten mM PB abolished responses to
all stimuli. The concentration of PB which produces a 70% inhibition of the
70 % of maximal developed tension with various stimuli was 0.98 mM
±0.2 for KC1, 2.23 mM ±0.13 for PE, 1.19 mM ±0.12 for MEFS, and 0.92 mM
±0.11 for NEFS. In subsequent experiments, 1 mM of PB was used for all
incubations. The phasic response induced by NEFS was not affected by 1 mM
of PB while the tonic response was nearly abolished. The same concentration
of PB attenuated peak and tonic responses induced by MEFS (Fig. 5). Removal 
of PB from the bath returned the responses to normal levels after 20 min.
This occurred at all concentrations.
Role of endothelium in PB attenuation of contractionIV.
Neither mechanical denudation nor pharmacological inhibition of the
endothelium had any effect on PB attenuation of VSM contraction 
(n=6; Fig. 6). This indicates that PB attenuation of contraction is not
mediated by the endothelium nor any relaxing factors that it releases.
Figure 4. Effect of increasing concentrations of pentobarbital (PB; 1 jiM-10 mM) on the (A) 
potassium chloride (KC1), (B) phenylephrine (PE), (C) muscle electrical field stimulation 
(MEFS), and (D) neuronal electrical field stimulation (NEFS) dose- or stimulus - 
response curves of the tonic component of contraction (n=12). There is a downward 
rather than a rightwad shift of the dose-response curve, suggesting that PB acts as a 
non-competitive inhibitor of KCl-induced contractions. Points below 0 indicate 
complete inhibition of KC1 induced contraction and relaxation.
o
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Figure 5. Representative responses to 30 sec train of 50 Hz stimulus
pulses of (A) muscle electrical field stimulation (MEFS; 3 ms, 
50 V) and (B) neuronal electrical field stimulation (NEFS;
0.3 ms, 50 V), both in the presence (red line)and absence (black 
line) of pentobarbital (IpM PB). PB does not alter the phasic 
component, yet it inhibits the tonic component of NEFS- 
induced contraction. PB attenuates both the phasic and the 



























Role of endothelium in pentobarbital (PB) attenuation of potassium chloride (KC1), 
phenylephrine (PE), muscle electrical field stimulation (MEFS), or neuronal electrical 
field stimulation (NEFS) induced tonic component of contraction contraction (n=6). 
Neither mechanical removal of endothelium, inhibition of endothelial derived 
relaxing factor formation by the L-arginine analogue L-NAME, nor guanylate cyclase 
inhibition with methylene blue (MB) had any effect on PB-induced attenuations of 
contraction by all stimuli. This suggests that PB-induced attenuations are not mediated 





































PB effects on Ca2+i and Ca2+0V.
Figures 7 and 8 illustrate that in the absence of Ca2+0/ responses to KC1
(n=6; Fig. 7A), PE (n=6; Fig. 8A), MEFS (n=6; Fig. 7B) and NEFS (n=6; Fig. 8B)
were reduced and not different from PB-treated segments. As Ca2+0 was
reintroduced to the bath (300 |iM-30 mM Ca2+0), all responses increased. In
contrast, KC1- and MEFS-induced phasic and tonic responses in PB treated
vessels showed only modest increases. In the presence of PB (10 pM), NEFS- 
and PE-induced phasic responses were unchanged, while the tonic responses
were inhibited. Thapsigargin (TSG) treatment and depletion of Ca2+i with Caf
in the presence of EGTA abolished all NEFS- and PE-induced contractions
(n=6; Fig. 9).
PB effects on frog sciatic nerveVI.
The propagation velocity of the compound action potential (CAP) in
the frog sciatic nerve incubated with 300 pM PB (29.75 m/s) showed no 
significant change from control (31.3 m/s; n=5). The duration of the CAP of 
PB (1 mM) treated nerves (1.15±0.03 ms) increased as compared to control
(1.43±0.05 ms, p <0.05; n=5) and returned to baseline 20 min after removing
PB from the bathing solution (Fig. 10A). The amplitude of the CAP decreased
significantly (p <.001; n=5) with PB treatment from 9.78±0.07 V to 5.98±0.04 V
and returned to baseline 40 min after PB removal (Fig. 10B).
Effects of 1 mM pentobarbital (PB, red line; control, black line) on (A) KC1 induced 
(100 mM) and (B) muscle electrical field stimulation (MEFS; 50 V, 3 MS, 10 Hz) phasic 
(1) and tonic (2) components of contraction with changes in extracellular Ca2+ ([Ca2+]0; 
n=6). As [Ca2+]0 is increased, PB attenuates significantly (*p<0.05) the phasic and tonic 
components of KC1- and MEFS-induced contraction in an identical manner. However, 
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Effects of 1 mM pentobarbital (PB, red line; control, black line) on (A) phenylephrine 
(PE; 50 pM) and (B) neuronal electrical field stimulation (NEFS; 50 V, 0.3 MS, 10 HZ) 
induced phasic (1) and tonic (2) components of contraction with changes in 
extracellular Ca2+ ([Ca2+]0; n=6). As [Ca2+]0 is increased, PB inhibits significantly 
(*p<0.05) the tonic component of PE- and NEFS-induced contraction but not the phasic. 
PB does not alter the contractile mechanism, since so long as Ca2+ is present the 
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Effect of intracellular Ca2+ ([Ca2+]i) depletion and ImM pentobarbital (PB) on NEFS and 
PE induced phasic component of contraction (n=6). As the sarcoplasmic reticulum 
Ca2+/Mg2+-ATPase was inactivated with thapsigargin (TSG, 10 pM) and [Ca2+]i depleted 
with caffeine (caf, 30 pM), the developed tension decreased significantly as compared 
with control. The developed tension in arterial segments treated with PB did not differ 












Figure 10. Effect of pentobarbital (PB, 1 mM) on (A) duration and (B) amplitude of the compound 
action potential (CAP) of frog sciatic nerve (single 1 ms, 4 V pulse; n=5). The duration 
of the CAP of PB treated nerves increased (1.4310.05 ms) as compared with control 
(1.1510.03 ms, *p<0.05). The amplitude of the CAP of PB treated nerves decreased 
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VII. PUFA incorporation into VSM sarcolemma
To ensure that PUFA (10, 20, 30 |iM) had been incorporated into the
membrane, cell survivability was compared for cells exposed at high
temperatures (42, 43, 44, 45, 46°C) for different time periods (15-90 min) with
control (n=6). The PUFA treated cells consistently had lower survivability as
compared with control (Fig. 11). The concentration of PUFA (20 |iM) chosen
was one that resulted in an acceptable cell survivability (<20% mortality;
Fig. 12).
VIII. PB effects on 45Ca2+ influx in PUFA treated and non-treated cells
PUFA and/or PB treatment exhibited a statistically different transient
45Ca2+ influx in resting cells over a range of temperatures (32, 34.5, 37, 39.5,
41 °C; n=6; Fig. 13). However, PUFA treatment, in cells depolarized with 
55 mM KC1, decreased 45Ca2+ influx by 2 nmol/mg of protein over the same
temperature range. Incubation with PB, also decreased 45Ca2+ influx in a
similar fashion (2 nmol/mg of protein). When PUFA treated cells were
incubated with PB, an additive inhibitory effect was noticed (50% decrease
from control; Fig. 13). These effects are best seen at the normal physiological
temperature (37°C; Fig. 14).
Effect of cell treatment with various concentrations of docosahexaenoic acid (22:6, a 
polyunsaturated fatty acid - PUPA, 10, 20, and 30 pM) on survivability of A/rs vascular 
smooth muscle cells (n=6). The 20 pM concentration of PUPA was used in experiments 



















Figure 12. Effects of temperature (420C, dotted squares; 430C, black squares) on the survivability of 
A/rs vascular smooth muscle cells treated with docosahexaenoic acid (22:6, a 
polyunsaturated fatty acid - PUFA, 20 pM) and control (n=6). PUFA treated cells 
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Figure 13. Effect of 30 |iM pentobarbital (PB) on non-depolarized (n=6) and KC1 induced (n=6)
45Ca2+ influx of docosahexaenoic acid (22:6, a polyunsaturated fatty acid - PUFA, 20 pM) 
treated A/rs vascular smooth muscle cells and control at 32, 34.5, 37, 39.5, and 42°C. 
Although 45Ca2+ influx was statistically significant at all temperatures and with all 
treatments (p<0.05), these differences are not physiologically significant since the 
difference between the highest and lowest 45Ca2+ influx was 0.4 nmol/mg of protein. 
This difference appears to be insignificant when compared to the difference observed in 
the depolarized state. At each temperature point tested, 45Ca2+ influx of cells treated 
with PB (N+PB), PUFA (PUFA), PUFA and PB (PUFA+PB) were significantly lower 
(p<0.05) than control (N); 45Ca2+ influx of PUFA cells treated with PB (PUFA+PB) were 
significantly lower (p<0.05) than cells treated with either PB (N+PB) or PUFA (PUFA). 
For control cells (N), 45Ca2+ influx increased significantly (p<0.05) with each succeeding 
temperature. For cells treated with PB (N+PB) and PUFA (PUFA), 45Ca2+ influx was 
significantly higher (p<0.05) after each temperature point after 34.5°C. For PUFA 
treated cells exposed to PB (PUFA+PB), 45Ca2+ influx was significantly greater after each 
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Figure 14. Effect of 30 |iM pentobarbital (PB) on non-depolarized and KCl-induced (55 mM) 45Ca2+ 
influx of docosahexaenoic acid (22:6, a polyunsaturated fatty acid - PUFA, 20 pM) treated 
A/rs vascular smooth muscle cells and control at 37°C (n=6). KCl-induced 45Ca2+ 
influx, of cells treated with PB (Control+PB), PUFA (PUFA), PUFA and PB (PUFA+PB) 
was significantly lower (p<0.05) than control; KCl-induced 45Ca2+ influx of PUFA cells 
treated with PB (PUFA+PB) was significantly lower (p<0.05) than cells treated with PB 
(Control+PB) and PUFA (PUFA). 45Ca2+ influx was statistically significant with all 
treatments (p<0.05). These differences are not physiologically significant since the 
difference between the highest and lowest 45Ca2+ influx was 0.4 nmol/mg of protein. 
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IX. Effects of pH on VSM contraction
PB solutions at high concentrations (>10 mM) are highly basic (8.5 pH).
When the pH of krebs solution was raised to 8.5 with NaOH, the 
depolarization dependent contractions were significantly decreased (1.9 g 
±0.13 for KCl-induced response, 2.8 g ±0.14 for MEFS-induced response;p<0.05) 
as compared with control (2.9 g ±0.15 for KCl-induced response, 3.8 g ±0.26 for
MEFS- induced response), while the receptor mediated contractions were
unchanged (2.67 g ±0.19 for PE-induced control response, 2.11 g ±0.25 for PE-
induced response at pH 8.4, 2.41 g ±0.22 for NEFS-induced control response.
and 2.76 g ± 0.20 for NEFS-induced response at pH 8.4; n=6; Fig. 15).
Figure 15. Effect of increased pH on vascular smooth muscle contraction stimulated by KC1
(100 mM), phenylephrine (PE, 50 pM), muscle electrical field stimulation (MEFS, 10 Hz, 
3 ms, 50 V), or neuronal electrical field stimulation (NEFS, 10 Hz, 0.3 ms, 50 V). As pH 
was increased to 8.4 with NaOH, KC1 and MEFS induced developed tensions were 
significantly decreased (p<0.05; n=6) as compared with control, whereas PE and NEFS 




















Mechanism of action of antagonistsI.
Pentobarbital (PB), a barbiturate, is used as an anesthetic for laboratory
animals. It is reported to inhibit vascular smooth muscle (VSM) contraction
(Altura and Altura, 1974; Wendling and Harakal, 1985; Moriyama et al, 1990;
Taga et al, 1990; Yakushiji et al, 1992). There are a number of ways a 
substance can antagonize a response stimulated by an agonist (Fig. 16). This
substance can act as a(n):
chemical antagonist, binding with the agonist, preventing the(1)
agonist from binding to the receptor.
pharmacokinetic antagonist, stimulating the breakdown of the 
agonist, decreasing the concentration of circulating agonist.
(2)
reversible competitive antagonist, competing for the receptor-(3)
site with the agonist.
irreversible competitive antagonist, competing for the receptor-(4)
site with the agonist, and once it binds, dissociates from the
receptor very slowly or not at all.
non-competitive antagonist, inhibiting at some point the chain(5)




Figure 16. Diagram showing the different ways that a substance can
inhibit an agonist induced response (D). It can do so by acting 
as: (A) a chemical antagonist, binding with the agonist, thus 
preventing the agonist from binding to the receptor, (B) a 
reversible competitive antagonist, competing for the receptor- 
site with the agonist, (C) a non-competitive antagonist, 
inhibiting at some point the chain of events that leads to the 
production of the response by the agonist, (E) a 
pharmacokinetic antagonist, stimulating the breakdown of the 
agonist, and decreasing the concentration of circulating agonist, 
(F) an irreversible competitive antagonist, competing for the 
receptor-site with the agonist, and once it binds, dissociates 
from the receptor very slowly or not at all, and (G) a 
physiological antagonist, stimulating the production of a 
substance that will inhibit the response downstream from the 
receptor. The two graphs at the bottom show dose response 
curves with different concentrations (0-10) of the various 
antagonists. The graph on the left shows a rightward shift of 
the dose response curve with increasing concentrations of the 
antagonist with the maximal response always achieved. This 
is an example of a reversible competitive antagonist. The 
graph on the right shows a downward shift of the dose 
response curve as the concentration of the antagonist is 
increased with the maximal response never achieved. This is 
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physiological antagonist, stimulating the production of a 
substance that will inhibit the response downstream from the
(6)
receptor.
We can rule out the first two possibilities by using different agonists. 
Furthermore, by analyzing the dose response curves in the presence of 
increasing concentrations of the antagonist, we observe the differences 
between competitive and non-competitive antagonism. If the substance is a 
competitive antagonist, it is constantly competing with the agonist for the 
receptor-site. The maximal response is always achieved but at higher agonist 
concentrations. Therefore, we see a shift of the dose response curve to the 
right. If the substance is a non-competitive antagonist, it does not affect the 
receptor-site, but rather its effect is on the receptor induced response. A
maximal response is never achieved at any concentration. This is seen as a 
downward shift of the dose response curve. A rightward shift is sometimes
observed in conjunction with a downward shift; however, a maximal
response is never achieved. The dose response curve of an irreversible 
competitive antagonist looks very much like the dose response curve of a 
non-competitive antagonist. Since the irreversible competitive antagonist
dissociates very slowly from the receptor, if at all, the inhibitory response is
not reversed with washing as it is with a non-competitive antagonist.
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Pentobarbital as an antagonistII.
Pentobarbital as a chemical or pharmacokinetic antagonistA.
When looking at pentobarbital (PB) induced attenuation of vascular
smooth muscle (VSM) contraction, we observed that PB (1 (iM - 10 mM)
inhibited contractions stimulated by KC1, phenylephrine (PE), muscle
electrical field stimulation (MEFS), and neuronal electrical field stimulation
(NEFS). Others have reported that PB (10 pM - 1 mM) inhibited epinephrine 
(EPI)- and KC1-, (Altura and Altura, 1974), KC1- and prostaglandin F2a (PGF2a)-
(Wendling and Harakal, 1985; Moriyama et ah, 1990), endothelin (E)- and 
KC1- (Taga et ah, 1990), KC1-, caffeine (caf)- and norepinephrine (NE)- 
(Yakushiji et ah, 1992) induced contractions. It is highly unlikely that PB
would interact with or stimulate the elimination of so many different
substances (KC1, EPI, PGF, E, caf, and NE). MEFS induced contractions are not
mediated by an agonist, rather the electrical field causes the membrane to 
depolarize. Since PB inhibits MEFS and agonist induced contractions, the 
probability that PB acts as a chemical or pharmacokinetic antagonist is not
likely.
Pentobarbital as an irreversible antagonistB.
PB induced inhibition of VSM contraction is reversible. After washing.
contractions induced by all stimuli return to baseline. This is supported in
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the literature (Altura and Altura, 1974; Wendling and Harakal, 1985; 
Moriyama et ah, 1990; Taga et ah, 1990; Yakushiji et ah, 1992). We can.
therefore, eliminate the possibility that PB acts as an irreversible antagonist.
Pentobarbital as a physiological antagonistC.
There are only a few possibilities that PB could act as a physiological
antagonist; stimulating Ca2+ efflux perhaps by stimulating the synthesis of 
cyclic GMP, or stimulating the Ca2+/Mg2+-ATPase, inhibiting calmodulin, 
inhibiting the contractile proteins, or stimulating the release of endothelium 
derived relaxing factor (EDRF). Nakamura et ah (1991) reported that PB did 
not stimulate the production of cGMP.
To rule out endothelial involvement, the endothelium can be
mechanically removed, as described by Liischer and Vanhoutte (1990);
endothelium derived relaxing factor (EDRF) synthesis can be also inhibited
with an L-arginine analog (L-NAME), as described by Ignarro (1991); and
VSM relaxation via EDRF-induced guanylate cyclase can be inhibited by 
methylene blue (MB), as described by King and Brenner (1991). These 
maneuvers on our preparations had no effect on PB induced attenuation of
VSM contraction (Fig. 6). Based on these results and those reported by others
(Altura and Altura, 1975a and 1975b; Nakamura et ah, 1991), we conclude that
PB induced attenuation of VSM contraction is not mediated by the
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endothelium, through stimulation of EDRF synthesis, nor by EDRF-induced
guanylate cyclase synthesis.
Ca2+ efflux could be activated by stimulation of the Ca2+/Mg2+-ATPase. 
Fernandez-Salguero et al. (1990), however, reported that PB changed the 
conformational state of the annulus around the Ca2+/Mg2+-ATPase,
inactivating it. This would rule out the possibility that PB stimulates Ca2+
efflux.
In the presence of PB, developed tensions induced by all stimuli in
normal media were greater than developed tensions in Ca2+ free media
(Fig. 7, 8). PB does not appear to affect the contractile apparatus nor
calmodulin since we observed that as long as Ca2+ is present, the vessel
segments contract. We have now ruled out the possibility that PB could act as 
a physiological antagonist. The two remaining possibilities are that PB acts as
either a reversible competitive antagonist or a non-competitive antagonist.
Pentobarbital as a reversible competitive or non-competitiveD.
antagonist
PB, in concentrations greater than 30 pM, significantly (p<0.05)
attenuated KC1-, PE-, MEFS-, or NEFS-induced VSM contraction (Fig. 4). Over
a range of concentrations, there was a downward rather than a rightward shift 
of the dose-response curves of the four stimuli, in the presence of PB, and
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agrees with the literature (Altura and Altura, 1975). However, at 
concentrations greater than 10 mM, tension could not be induced with any
stimuli.
It appears that the inhibition PB exerts on VSM contraction is not by 
competing with these stimuli, thus supports previous reports (Altura and 
Altura, 1974; Moriyama et al., 1990). In competitive inhibition, a submaximal
dose of the inhibitor binds a given number of receptors or channels; 
however, as long as enough channels are activated, a maximal response will
be achieved. A greater concentration of agonist is required to elicit a maximal
response; therefore, a rightward shift of the dose response curve is observed. 
Once all the receptors are inhibited with a maximal dose of the competitive 
inhibitor, a maximal response will be not achieved (Ross, 1990). With a non­
competitive inhibitor, an inhibitor that attenuates a response by a mechanism 
other than competing directly for the same receptor as the agonist, a maximal
response is never achieved. How much agonist is delivered will not matter, 
since the receptor-induced response is not inhibited (Ross, 1990). Since all 
dose response curves show a downward shift with increasing doses of PB
rather than a rightward shift, we concluded that PB acts as a non-competitive
inhibitor of depolarization-dependent and receptor-operated contractions. 
Ways by which PB may attenuate VSM contraction, other than by interfering 
with the receptor activation or depolarization, include: inhibition due to the
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high pH of high concentrations of PB in solution (>1 mM) and inhibition of 
Ca2+ influx through either voltage dependent or receptor operated Ca2+
channels (VDCC and ROCC, respectively).
The pH effect of pentobarbitalE.
The pH of the media containing PB is reported to be high
(Yakushiji et al, 1992), and might explain PB's effect on VSM contraction. In
our experiments, the pH of 5 ml Krebs solution containing 10 mM PB was
8.45. If the effects of PB on VSM were due to the high pH of the PB containing
media, then we would expect to see an enhancement rather than relaxation of
contraction as reported by Austin and Wray (1993). Austin and Wray
investigated the effects of extracellular pH on rat mesenteric artery developed 
tension and on its intracellular pH. They showed that an increase in 
extracellular pH resulted in an increase in both developed tension and the
intracellular pH. When extracellular pH was held constant and the
intracellular pH was increased, developed tension increased. On the other 
hand, holding the intracellular pH constant while increasing extracellular pH
did not alter the development of arterial tension, implying a correlation 
between intracellular pH and tension. When we increased pH to 8.4 with 
NaOH in place of PB, KC1- and MEFS-induced contractions were significantly
lower than control; whereas, the PE- and NEFS-induced contractions were
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not different when compared with control. These data suggest that an 
extracellular pH of 8.4 causes a decrease in KC1- and MEFS-induced developed 
tension as compared with control, and implies that contractions induced by 
KC1 and MEFS are more sensitive to pH than those induced by PE and NEFS. 
To minimize whatever pH effect PB may have, the pH of the bath media was
held at a constant 7.4 throughout the experiments.
Our results differ from those of Austin and Wray (1993). The pH of the
NaOH containing solution is 8.4 initially. After the 20 min incubation period, 
the pH returned to 7.4 due to the constant exposure to 5% CO2. Austin and 
Wray (1993) showed that as the extracellular pH is increased, the intracellular 
pH will increase as well and that the time required to reach half-peak of
intracellular pH is 38 sec. The 20 min incubation time of our experiments
was within the 38 sec half time and allowed the pH of the bath to return to
7.4 and the intracellular pH to respond to this change. If the pH of the bath
had been kept at a constant 8.4 throughout the 20 min incubation period, our
results most likely might have agreed with Austin and Wray.
Mechanism of pentobarbital induced attenuation of VSM contraction 
Thus far we have eliminated chemical antagonist, physiological 
antagonist, pharmacokinetic antagonist, irreversible or reversible competitive 
antagonist as ways that PB induces attenuation of VSM contraction as well as
in.
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the pH effect that PB may exert. Let us shift focus to the VSM itself and the
possible ways that PB induces attenuation directly on VSM contraction.
Mechanism of VSM contractionA.
Upon stimulation of vessel segments with PE or NEFS, the contractile
process is mediated via activation of oti-adrenergic receptors (Fig. 17).
Phospholipase C (PLC), induced by oci stimulation, catalyzes the breakdown of
phosphoinositol 4,5-diphosphate (PIP2) into diacylglycerol (DAG) and inositol 
1,4,5-triphosphate (IP3). IP3 binds to receptors on the SR resulting in the
release of Ca2+. This release of Ca2+ from the SR is responsible for the phasic 
component of receptor mediated contraction. In order for the contraction to
be maintained, influx of extracellular Ca2+ is needed. DAG, with Ca2+, is
thought to increase the probability of the opening of ROCC leading to an
influx of Ca2+ (Campbell et al, 1990; van Breemen, 1989; Nelson et al, 1990;
McDonald et al., 1994). Extracellular Ca2+ influx is responsible for the tonic
component of receptor mediated contraction. Stimulating the vessel 
segments with KC1 or MEFS, in the presence of tetrodotoxin (TTX), results in 
contraction which is dependent on the opening of VDCC caused by the 
depolarization of the membrane with subsequent Ca2+ influx (Campbell et al.
1990; van Breemen, 1989; Nelson et al, 1990; McDonald et al., 1994; Fig. 17).
Figure 17. Summary diagram of postulated manner in which KC1, phenylephrine (PE), muscle 
electrical field stimulation (MEFS) and neuronal electrical field stimulation (NEFS) 
induce contraction. KC1 and MEFS induces vascular smoth muscle (VSM) contraction 
by causing a conformational change of the voltage-dependent Ca2+channels to an open 
state. This makes the VSM membrane permeable to Ca2+ and Ca2+ influx increases, an 
important mechanism for maintaining tonic contraction. NEFS induces VSM 
contraction by stimulating the release of norepinephrine (NE) from the perivascular 
nerves. NE and PE bind to adrenergic receptors which stimulate inositol-1,4,5- 
triphosphate (IP3) and diacyl glycerol (DAG) generation from phosphatidylinositol 
phosphate (PIP2)- IP3 binds to receptors on the sarcoplasmic reticulum, thus 
stimulating the release of Ca2+. DAG, with Ca2+, not only makes the contractile 
apparatus more sensitive toward contraction, but also induces opening of Ca2+ channels 
through intracellular receptors. This causes an influx of Ca2+ which is important for 

























In this latter case both the phasic and tonic components of contraction are due 
to the same contributing factor, influx of Ca2+.
Effects of pentobarbital on cellular Ca2+ dynamics 
Examination of the effects of PB on cellular Ca2+ dynamics revealed
B.
that PB inhibited only the tonic component of PE- and NEFS-induced VSM
contraction, leaving the phasic component intact. On the other hand, PB 
inhibited both the tonic and phasic components of KC1- and MEFS-induced
contraction. The phasic component of adrenergic receptor stimulation is due 
solely to release of Ca2+ from the SR, while the tonic component is due to
influx of Ca2+ through ROCC (Campbell, 1985; McDonald et al, 1994). In
contrast both the phasic and tonic components of depolarization-induced
contraction are due to influx of Ca2+ through VDCC.
In the presence of PB, developed tensions induced by all stimuli in
normal media were greater than developed tensions in Ca2+ free media.
These results suggest that (1) PB does not appear to affect the contractile 
apparatus since we observed that as long as Ca2+ is present, the vessel 
segments contract, and (2) PB affects Ca2+ influx through both ROCC and 
VDCC, but not on IP3 production, IP3 action, or release of Ca2+ from the SR 
which are responsible for the phasic component in adrenergic receptor
stimulation.
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Thapsigargin (TSG) was used to inactivate the SR Ca2+/Mg2+-ATPase, 
and the intracellular stores were depleted with Caf and EGTA, to ensure that
the phasic component of adrenergic receptor stimulation is indeed due to
intracellular Ca2+. After such treatment, the [Ca2+]i is abolished and the
cytosolic Ca2+ present is due to Ca2+ influx only. If these experiments are
conducted in a Ca2+ free solution, then VSM contractions should not be
elicited since there is no Ca2+ available and proves that the phasic contraction
is due to [Ca2+]i. In our experiments, we observed no differences between
control and PB-incubated vessels under these conditions. Thus, we
concluded that PB does not alter [Ca2+]i or its release.
Pentobarbital as a local anestheticC.
Since VSM acts as a syncytium and exhibits properties of a cable (Abe
and Tomita, 1968), it might be possible for PB to affect the interaction between
VSM cells. Does PB affect the propagation of depolarization in VSM? To
examine this hypothesis, we looked at the effects of PB on nerves. When frog 
sciatic nerves were stimulated after exposure to PB, the propagation of the
compound action potential (CAP) was unchanged as compared with control.
but both the duration and the amplitude of the CAP decreased. This is in
agreement with Richards (1972,1982) who reported that PB did not exhibit a
local anesthetic effect, since propagation of CAP is not altered with PB
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treatment. PB depresses synaptic transmission by interfering with chemical 
transmission but not by blocking impulse conduction (Richards, 1982;
Richards and Strupinski, 1986). We had hoped to look at the effects PB would
have on the propagation of depolarization on VSM by conducting the same 
experiments on vessel segments but we did not have the necessary
equipment to perform these experiments.
Effect of pentobarbital on VSM membraneD.
Since PB had no effect on endothelial or intracellular calcium function
but appeared to interfere with Ca2+ influx, we decided to look into PB's effect 
on the membrane itself. PB is thought to increase artificial monolayer and
nerve membrane fluidity (Lee, 1976; Daniell and Harris, 1988). We 
hypothesized that PB might increase membrane fluidity, inhibiting Ca2+
channels from opening, and decreasing Ca2+ influx. To examine our
hypothesis, 45Ca2+ influx was measured as a function of altered membrane
fluidity in A/rs VSM cells. Fluidity was increased by two means (1) treatment 
with docosahexaenoic acid (22:6), a polyunsaturated fatty acid (PUPA) and (2) 
exposure to a range of temperatures (32, 34.5, 37, 39.5, 41°C), as a comparison
to the effect of PB incubation (30 pM, 20 min). PUPA and/or PB treatment
exhibited statistically different transient 45Ca2+ influx in resting cells over the
experimental temperature range. These changes, however, are not
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physiologically significant since the difference from the highest to the lowest 
45Ca2+ influx is 0.4 nmol/mg of protein. The intracellular Ca2+ concentration 
rises from 10 nM to 1 jiM in each cell, and a rise of 0.4 nmol/mg of protein is
too small to cause any physiological changes. PUFA treatment, in cells 
depolarized with 55 mM KC1, decreased 45Ca2+ influx by 2 nmol/mg of
protein over the same temperature range. Incubation with PB had the same
effect as PUFA. When PUFA treated cells were incubated with PB, an
additive inhibitory effect was noticed (50% decrease from control) (Fig. 14).
All the differences were found to be statistically significant (pcO.OOl).
Temperature has long been an enigma to scientists investigating
membrane fluidity. It has long been accepted that anesthetics, and
pentobarbital in this case, increase the neurolemmal fluidity (Seeman, 1975).
If the mechanism of action through which anesthetics induce anesthesia were 
by increasing membrane fluidity, then increasing membrane fluidity by other
means, such as increasing temperature, would hypothetically cause
anesthesia. This is not what is observed (Seeman, 1975). Our results point to
the same kind of effect. As temperature increases, Ca2+ influx also increases. 
However, increasing temperature not only causes a general increase in 
membrane fluidity, but also intracellular metabolic rate, Ca2+ influx, 
chaperonin production, and many other effects. In contrast, docosahexaenoic 
acid (22:6), appears to change only the fluidity of particular domains of the
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membrane (Viret, Daveloose and Leterrier, 1990; Lentz, 1988), and not
metabolic rate, stimulation of chaperonin production, or other cell processes
(Viret, Daveloose and Leterrier, 1990; Lentz, 1988). The docosahexaenoic acid
treated cells displayed a decreased Ca2+ influx as compared with control. This 
observation suggests that docosahexaenoic acid appears to affect domains
close to VDCC. PB treated cells exhibited a similar decrease in Ca2+ influx.
This observation suggests that PB also affects the domains close to VDCC.
When docosahexaenoic acid treated cells are exposed to PB, a further decrease
in Ca2+ influx is observed suggesting that the two treatments act in an
additive fashion.
Crews (1982) and Raber and Bast (1989) have demonstrated that an
increase in membrane fluidity increased the rate of protein-protein collisions.
such as receptor/G protein interaction or receptor/phosphorylation 
stimulation. A higher degree of lipid structure, a decreased membrane 
fluidity, restricted the rate of protein-protein collisions. We observed that PE
induced VSM contraction in the presence of lower concentrations of PB 
(1-100 pM) were greater than control. In the presence of higher
concentrations of PB (1 and 10 mM), PE induced contractions were lower than
control. At lower concentrations, PB, possibly, increases the rate of PE 
induced protein-protein collisions causing a greater response as compared to 
control. At higher PB concentrations, PB may increase the fluidity of the
Diagram of proposed mechanism of action of PB attenuation of vascular smooth 
muscle contraction. Under normal conditions (A), Ca2+ enters through open Ca2+ 
channels. PB enters the phospholipid bilayer (B), causes an increase in fluidity, inhibits 










membrane so much that the rate of protein-protein collision decreased 
causing a lower response as compared to control.
Summary and conclusionE.
In summary, we have confirmed previous findings that PB attenuates
VSM contraction by acting as a non-competitive non-selective, Ca2+ channel 
blocker, thus inhibiting Ca2+ influx rather than affecting intracellular Ca2+
release; and that its action does not arise from interaction with the
endothelium. Our results have furthered the understanding that PB
decreases KCl-induced 45Ca2+ influx in the same manner as when membrane
fluidity is increased with PUPA, suggesting that PB causes an increase VSM
membrane fluidity, thus preventing the opening of Ca2+ channels and
ultimately inhibiting Ca2+ influx (Fig. 18). In conclusion, our results strongly 
suggest that PB induced attenuation of VSM contraction is through an
increase in membrane fluidity in the microdomain surrounding both VDCC
and ROCC, thus inhibiting the opening of Ca2+ channels, and ultimately
inhibiting Ca2+ influx.
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